Bibliographical noteFunding Information:
Author Contributions: Dr Bitterman, Ms Kao, and Dr London had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Bitterman, Bona, Terezakis, London, Haas-Kogan. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Bitterman, Laurie, Kao, Terezakis, London, Haas-Kogan. Critical revision of the manuscript for important intellectual content: Bitterman, Bona, Terezakis, London, Haas-Kogan. Statistical analysis: Bitterman, Kao, London. Obtained funding: Haas-Kogan. Administrative, technical, or material support: Laurie, Haas-Kogan. Supervision: Terezakis, London, Haas-Kogan. Conflict of Interest Disclosures: Dr Bitterman reported personal fees from Agios Pharmaceuticals outside the submitted work. Dr Bona reported grants from the National Institutes of Health, grants from Charles Hood Foundation, and grants from Family Reach Foundation during the conduct of the study. Dr Terezakis reported grants from Elekta Industries and grants from ASELL outside the submitted work. Dr London reported personal fees from ArQule, Inc; personal fees from American Association for Cancer Research; and personal fees from Jubilant Draximage outside the submitted work. No other disclosures were reported.
Funding/Support: The data were obtained from the Children’s Oncology Group (COG), which is supported by NCTN Operations Center Grant U10CA180886 and NCTN Statistics & Data Center Grant U10CA180899 and IROC Grant U24CA180803.
Funding/Support: This study was funded by grant T32 CA009672 from the NCI (Dr Wang), the National Clinician Scholars Program (Dr Berlin), grant R37CA222885 from the NCI (Dr Skolarus), and grant K08 HS026030-02 from the AHRQ (Dr Dossett).
Copyright 2020 Elsevier B.V., All rights reserved.
PubMed: MeSH publication types
- Journal Article